期刊文献+

强直性脊柱炎伴发葡萄膜炎16例临床分析 被引量:3

Uveitis associated with ankylosing spondylitis:a clinical analysis of 16 case
暂未订购
导出
摘要 目的:探讨强直性脊柱炎(AS)伴发葡萄膜炎的临床特征、诊断、治疗及预后,提高对该病的认识。方法:回顾性分析从2006年1月至2008年10月在本院就诊的AS伴发葡萄膜炎患者的临床特点、诊断、治疗和预后。结果:AS伴发葡萄膜炎患者16例(17只眼),男14例,女2例;AS发病年龄14~47岁,平均(32±12)岁;葡萄膜炎发病年龄15~52岁,平均(33±14)岁,病史7d~4年,持续时间为10~42d,平均(28±8)d,有反复发作;15例为单眼受累,双眼受累者1例(6.25%),为单眼交替发病;所有患眼均表现为急性非肉芽肿性前葡萄膜炎;16例(100%)患者均有腰痛史,X线影像学检查显示均为骶髂关节炎,15例(93.75%)HLA-B27检查为阳性;经糖皮质激素和睫状肌麻痹剂眼液治疗后,15例好转,1例效果不佳,使用肿瘤坏死因子-α抑制剂治疗后好转。结论:AS伴发葡萄膜炎多发生于男性,多呈急性、非肉芽肿性前葡萄膜炎表现;与HLA-B27和病情活动有关;根据典型的临床特征和影像学改变可确诊;主要治疗方法为滴用睫状肌麻痹剂和糖皮质激素眼液,并要积极控制AS,对治疗效果不佳者可使用肿瘤坏死因子-α抑制剂;绝大多数患者预后良好。 Objective To investigate the clinical characteristics of uveitis associated with ankylosing spondylitis (AS). Methods Analyzing the clinical, laboratory and treatment data of uveitis associated with AS patients hospitalized from 2006.1.1 to 2008.10.31 retrospectively. Results Of 16 (17 eyes) patients, 14 were male. The median age of AS was (32 ± 12) (14 - 47) years old and uveitis was (33 ± 14)( 15 - 52) years old; the history of uveitis was 7 days to 4 years and the median duration was (28 ± 8) (10 - 42) days. All cases were acute nongranulomatous anterior uveitis and could break out repeately; 15 (93.75%) cases were monocular involvement, while 1 (6.25%) case was binocular involvement (monocular inflamation alternately). All cases had typical history of lower back pain and definitely radiologieal evidences of sacroiliitis. HLA-B27 of 15 (93.75%) cases was positive. All cases were treated with corticosteroids and cycloplegic agent eyedrops, 15 (93.75%) cases were improved, while 1 (6.25%) cases was improved by using tumor necrosis factor-a (TNF-a) inhibitor simultaneously. Conclusion Uveitis associated with AS, mostly occurs in male, is characterized by acute nongranulamatous anterior uveitis. It is related with HLA-B27 and the activity of AS. Diagnosis is made according to typical clinical features and radiological evidences of sacroiliitis. Tightly contol the activity of AS and the treatment with corticosteroids and cycloplegic agent eyedrops are able to resolve the inflammation rapidly. The patients who can not contol by the traditional treatment also can be improved by using TNF-a inhibitor simultaneously. The prognosis is good in most patients.
出处 《实用医学杂志》 CAS 北大核心 2010年第7期1187-1189,共3页 The Journal of Practical Medicine
关键词 脊柱炎 强直性 葡萄膜炎 诊断 治疗 Spondylitis ankylosing Uveitis Diagnosis Therapy
  • 相关文献

参考文献7

  • 1张乃峥,曾庆馀,张凤山,陈纪邦,施全胜,要庆平,赵岩,曾学军,董怡.中国风湿性疾病流行情况的调查研究[J].中华风湿病学杂志,1997,1(A01):34-38. 被引量:131
  • 2Van der linden S, VHA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria [ J ]. Arthritis Rheum, 1984,27 (4) : 361-368.
  • 3Garrett S, Jenkinson T, Kennedy L G, et al. A new approach to defining disease status in ankylosing spondylitis:the Bath Ankylosing Spondylitis Disease Activity Index [J ]. J Rheumatol, 1994,21 (12): 2286-2291.
  • 4Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis:the development of the Bath Ankylosing Spondylitis Functional Index [J]. J Rheumatol, 1994,21 ( 21 ) : 2281-2285.
  • 5Boonen A. A review of work-participation, cost-of-illness and costeffectiveness studies in ankylosing spondylitis [J]. Nat Clin Pract Rheumatol, 2006,2 ( 10 ) : 546 -553.
  • 6Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B~ homozygosity in ankylosing spondylitis [ J ]. Ann Rheum Dis, 2006,65 (6) : 775-780.
  • 7Levy-Clarke G, Grace T, Nussenblatt L, et al. Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis [J]? Nat Clin Pract Rheumatol,2006,2(2):72-73.

共引文献130

同被引文献19

  • 1杨培增,张震,周红颜,黄祥坤,俞琼,王红,李兵,高杨,朱莲香.葡萄膜炎致盲目特点及原因探讨[J].中华眼底病杂志,2005,21(6):350-352. 被引量:30
  • 2毕毅敏,孙长录.强直性脊柱炎伴发葡萄膜炎21例临床分析[J].眼科研究,2006,24(4):426-426. 被引量:1
  • 3林智明,古洁若.强直性脊柱炎治疗现状及其进展[J].国际内科学杂志,2007,34(1):39-42. 被引量:17
  • 4El Maghraoui A. Extra-articular manifestations of ankylosing spon- dylitis: prevalence, characteristics and therapeutic implications [J]. Eur J Intern Med, 2011, 22(6): 554-560.
  • 5Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: A systematic literature re- view [J]. Ann Rheum Dis, 2008, 67(7): 955-959.
  • 6Hoekzema R, Verhagen C, Van Haren M, et al. Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6 [J]. Invest Ophthalmol Vis Sci, 1992, 33(3): 532-539.
  • 7Van Der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis, a proposal for modification of the new york criteria [J]. Arthritis Rheum, 1984, 27: 361-368.
  • 8Wakefield D, Chang J, Amjadi S, et al. What is new HLA-B27 acute anterior uveitis ? [J]. Ocul Immunol Inflamm, 2011, 19: 139-144.
  • 9Sieper J, Koenig A, Baumgartner S, et al. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials [J]. Ann Rheum Dis, 2010, 69: 226-229.
  • 10Rosenbaum J. Effect of etanercept on iritis in patients with ankylos- ing spondylitis [J]. Arthritis Rheum, 2004, 50: 3736-3737.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部